Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells

Molecular Vision

Volumn 19, Issue , 2013, Pages 2385-2392

  Balaiya, Sankarathi ^a   Murthy, Ravi K ^a   Chalam, Kakarla V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COBALT CHLORIDE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CHOROIDAL VASCULAR ENDOTHELIAL CELL; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOXIA; IMMUNOBLOTTING; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL;

ANTIOXIDANTS; CASPASE 3; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHOROID; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; SIGNAL TRANSDUCTION; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888330623     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Coleman HR, Chan C, Ferris FL, Chew EY. Age-related macular degeneration. Lancet 2008; 372:1835-45. [PMID: 19027484]
2. National Advisory Eye Council (US). Vision Research: A National Plan 1994-1998. NIH publication no. 93-3186. Bethesda, MD:US Department of Health and Human Services; 1993.
3. Balaiya S, Khetpal V, Chalam KV. Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2α. Mol Vis 2012; 18:114-20. [PMID: 22275802]
4. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224:274-83. [PMID: 17306316]
5. Niles RM, McFarlanda M, Weimera MB, Redkarb A, Fub Y, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 2003; 190:157-63. [PMID: 12565170]
6. Szende B, Tyihák E, Király-Véghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med 2000; 32:88-92. [PMID: 10926121]
7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of Resveratrol, a natural product derived from grapes. Science 1997; 275:218-20. [PMID: 8985016]
8. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 21:381-406. [PMID: 11375442]
9. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1A and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 2005; 4:1465-74. [PMID: 16227395]
10. Trapp V, Parmakhtiar B, Papazian V, Willmott L, Fruehauf JP. Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis 2010; 13:305-15. [PMID: 20927579]
11. Yang YT, Weng C, Ho C, Yen G. Resveratrol analog-3,5,49-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol Nutr Food Res 2009; 53:407-16. [PMID: 19072741]
12. Zhang H, Fan H, Xu N, Duan X, Duan X, Liu B. Effect of cell cycle and radiosensitivity by CoCl2 induced hypoxia in Eca109 cells. Chinese-German J Clin Oncol 2008; 7:230-2.
13. Balaiya S, Malyapa R, His W, Murthy RK, Chalam KV. Evaluation of proton beam radiation sensitivity of proliferating choroidal endothelial and retinal ganglion cells with clonogenic assay. Cutan Ocul Toxicol 2012; 31:14-9. [PMID: 21861774]
14. Stefánsson E, Geirsdóttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011; 30:72-80. [PMID: 20951826]
15. Bråkenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001; 15:1798-800. [PMID: 11481234]
16. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 2002; 958:439-47. [PMID: 12470882]
17. Nagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest Ophthalmol Vis Sci 2007; 48:4232-9. [PMID: 17724212]
18. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341:1103-4. [PMID: 8097009]
19. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2001; 28:55-9. [PMID: 11153537]
20. Kundu JK, Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kB and AP-1 as potential targets. Mutat Res 2004; 555:65-80. [PMID: 15476852]
21. Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 2006; 231:113-22. [PMID: 16356836]
22. Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 2007; 72:1466-75. [PMID: 17848600]
23. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M, Aggarwal BB. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003; 102:987-95. [PMID: 12689943]
24. Khan AA, Dace DS, Ryazanov AG, Kelly J, Apte RS. Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway Am J Pathol 2010; 177:481-92. [PMID: 20472894]
25. Cao Z, Fang J, Xia C, Shi XL, Jiang BH. eds-3,4,5′-trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004; 10:5253-63. [PMID: 15297429]
26. Stiehl DP, Jelkmann W, Wenger RH, Hellwig-Bürgel T. Normoxic induction of the hypoxia-inducible factor 1a by insulin and interleukin-1h involves the phosphatidylinositol-3-kinase pathway. FEBS Lett 2002; 512:157-62. [PMID: 11852072]
27. Ivan M, Konda K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr. HIF-1a targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292:464-8. [PMID: 11292862]
28. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-1a to the von Hippel-Lindau ubiquitilation complex by O2-regulated prolyl hydroxylation. Science 2001; 292:468-72. [PMID: 11292861]
29. Salceda S, Caro J. Hypoxia-inducible factor-1a protein is rapidly degraded by the ubiquitin-proteosome system under normoxic conditions: its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997; 272:22642-7. [PMID: 9278421]
30. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1a is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95:7987-92. [PMID: 9653127]
31. Su JL, Lin MT, Hong CC, Chang CC, Shiah SG, Wu CW, Chen ST, Chau YP, Kuo ML. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 2005; 26:1-10. [PMID: 15217905]
32. Roduit R, Schorderet DF. MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE-19 cells. Apoptosis 2008; 13:343-53. [PMID: 18253836]
33. She QB, Huang C, Zhang Y, Dong Z. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinog 2002; 33:244-50. [PMID: 11933078]
34. Narayanan BA, Narayanan NK, Re GG, Nixon DW. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 2003; 104:204-12. [PMID: 12569576]
35. Kuo PL, Chiang LC, Lin CC. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 2002; 72:23-34. [PMID: 12409142]
36. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA, Davis PJ. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 2002; 168:748-55. [PMID: 12131363]
37. Jiang H, Zhang L, Kuo J, Kuo K, Gautam SC, Groc L, Rodriguez AI, Koubi D, Hunter TJ, Corcoran GB, Seidman MD, Levine RA. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol Cancer Ther 2005; 4:554-61. [PMID: 15827328]
38. Morris GZ, Williams RL, Elliott MS, Beebe SJ. Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate 2002; 52:319-29. [PMID: 12210493]
39. Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM, Kolb JP. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 2002; 117:842-51. [PMID: 12060119]
40. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002; 8:893-903. [PMID: 11895924]
41. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999; 20:237-42. [PMID: 10069459]